Publications by authors named "Graham Parry"

Claim this Profile
S
Signal regulating proteins (SIRPs) participate in sarcoidosis granuloma formation by promoting immune cell aggregation.
Marc A Judson, Mark W Julian, Llewellyn Foulke, Sandip Panicker, Soe H Arker, Graham Parry

Respir Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SAR443809: a selective inhibitor of the complement alternative pathway, targeting complement factor Bb.
Vaishnavi Rajagopal, Nina Leksa, Ronald Gorham, Siddharth Jindal, Soumya Nair, Graham Parry

Blood Adv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-C1s humanized monoclonal antibody SAR445088: A classical pathway complement inhibitor specific for the active form of C1s.
Ken T Simmons, Joanne Chan, Sami Hussain, Eileen L Rose, Kate Markham, Graham C Parry

Clin Immunol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Classical Complement Pathway Inhibition in a "Human-On-A-Chip" Model of Autoimmune Demyelinating Neuropathies.
John W Rumsey, Case Lorance, Max Jackson, Trevor Sasserath, Christopher W McAleer, Graham Parry

Adv Ther (Weinh)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specific Inhibition of the Classical Complement Pathway Prevents C3 Deposition along the Dermal-Epidermal Junction in Bullous Pemphigoid.
Patricia Colchete Freire, Cristina Herraez Muñoz, Ulla Derhaschnig, Christian Schoergenhofer, Christa Firbas, Graham C Parry

J Invest Dermatol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of a C1s Inhibitor on the Efficacy of Anti-Capsular Antibodies against and .
Lisa A Lewis, Sandip Panicker, Rosane B DeOliveira, Graham C Parry, Sanjay Ram

Immunohorizons· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial.
Ulrich Jäger, Shirley D'Sa, Christian Schörgenhofer, Johann Bartko, Ulla Derhaschnig, Graham C Parry

Blood· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C1s Inhibition by BIVV009 (Sutimlimab) Prevents Complement-Enhanced Activation of Autoimmune Human B Cells In Vitro.
Pavel A Nikitin, Eileen L Rose, Tony S Byun, Graham C Parry, Sandip Panicker

J Immunol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nulliparity is associated with subtle adverse metabolic outcomes in overweight/obese mothers and their offspring.
Sumudu N Seneviratne, José G B Derraik, Yannan Jiang, Lesley M E McCowan, Silmara Gusso, Graham K Parry

Clin Endocrinol (Oxf)· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blockade of HLA Antibody-Triggered Classical Complement Activation in Sera From Subjects Dosed With the Anti-C1s Monoclonal Antibody TNT009-Results from a Randomized First-in-Human Phase 1 Trial.
Jakob Mühlbacher, Bernd Jilma, Markus Wahrmann, Johann Bartko, Farsad Eskandary, Graham C Parry

Transplantation· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complement-Mediated Enhancement of Monocyte Adhesion to Endothelial Cells by HLA Antibodies, and Blockade by a Specific Inhibitor of the Classical Complement Cascade, TNT003.
Nicole M Valenzuela, Kimberly A Thomas, Arend Mulder, Graham C Parry, Sandip Panicker

Transplantation· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regimens of fetal surveillance of suspected large-for-gestational-age fetuses for improving health outcomes.
Katherine A T Culliney, Graham K Parry, Julie Brown, Caroline A Crowther

Cochrane Database Syst Rev· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uncoupling complement C1s activation from C1q binding in apoptotic cell phagocytosis and immunosuppressive capacity.
Lucrezia Colonna, Graham C Parry, Sandip Panicker, Keith B Elkon

Clin Immunol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human secreted tau increases amyloid-beta production.
Jessica Bright, Sami Hussain, Vu Dang, Sarah Wright, Bonnie Cooper, Graham Parry

Neurobiol Aging· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a new epitope in uPAR as a target for the cancer therapeutic monoclonal antibody ATN-658, a structural homolog of the uPAR binding integrin CD11b (αM).
Xiang Xu, Yuan Cai, Ying Wei, Fernando Donate, Jose Juarez, Graham Parry

PLoS One· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TNT003, an inhibitor of the serine protease C1s, prevents complement activation induced by cold agglutinins.
Ju Shi, Eileen L Rose, Andrew Singh, Sami Hussain, Nancy E Stagliano, Graham C Parry

Blood· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antenatal exercise in overweight and obese women and its effects on offspring and maternal health: design and rationale of the IMPROVE (Improving Maternal and Progeny Obesity Via Exercise) randomised controlled trial.
Sumudu N Seneviratne, Graham K Parry, Lesley Me McCowan, Alec Ekeroma, Yannan Jiang

BMC Pregnancy Childbirth· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of tumor cell migration by LD22-4, an N-terminal fragment of 24-kDa FGF2, is mediated by Neuropilin 1.
Ling Zhang, Graham C Parry, Eugene G Levin

Cancer Res· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crystal structures of two human vitronectin, urokinase and urokinase receptor complexes.
Qing Huai, Aiwu Zhou, Lin Lin, Andrew P Mazar, Graham C Parry

Nat Struct Mol Biol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacology of the novel antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2): observation of a U-shaped dose-response curve in several preclinical models of angiogenesis and tumor growth.
Fernando Doñate, Graham C Parry, Yuval Shaked, Harvey Hensley, Xiaojun Guan

Clin Cancer Res· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An anti-urokinase plasminogen activator receptor (uPAR) antibody: crystal structure and binding epitope.
Yongdong Li, Graham Parry, Liqing Chen, Jennifer A Callahan, David E Shaw

J Mol Biol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural basis of interaction between urokinase-type plasminogen activator and its receptor.
Cyril Barinka, Graham Parry, Jennifer Callahan, David E Shaw, Alice Kuo

J Mol Biol· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A non-RGD-based integrin binding peptide (ATN-161) blocks breast cancer growth and metastasis in vivo.
Parisa Khalili, Ani Arakelian, Gaoping Chen, Marian L Plunkett, Ivy Beck, Graham C Parry

Mol Cancer Ther· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure of human urokinase plasminogen activator in complex with its receptor.
Qing Huai, Andrew P Mazar, Alice Kuo, Graham C Parry, David E Shaw

Science· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of crystals of an inhibitory antibody of urokinase plasminogen activator receptor (uPAR) with hydrogen peroxide and low protein concentration.
Yongdong Li, Xiaoli Shi, Graham Parry, Liqing Chen, Jennifer A Callahan

Protein Pept Lett· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis